Gary Cheng

Gary leads Health Advances’ Hong Kong office and is focused on growing the firm’s practice in the Asia Pacific with pharma, biotech, medtech, and private equity firms.

Gary brings over three decades of healthcare experience in general management (Aventis, Chiron, and Biosite) and mergers and acquisitions (Alere and Becton Dickinson) in the Asia Pacific region. He has expert knowledge in the fields of oncology and cardiovascular medicine in pharma, and point of care expertise in diagnostics. During his fourteen years at Novartis, he managed the global launch of one of the leading medicines in the oncology portfolio.

While at BD, Gary identified over fifty acquisition, licensing, and partnership targets in China, Japan, Southeast Asia, and India and led the integration of Carefusion in the Greater Asia region.

Immediately prior to joining Health Advances, Gary was a Partner/Managing Director at Stout Bluepeak Asia where he worked in portfolio planning, mergers & acquisitions, and capital raising for both regional multinational firms start-up firms in Asia.

He has lived and worked professionally in Japan, Hong Kong, Singapore, and Switzerland.

Gary received his BA with honors in Psychology and Biology from Brown University and his MS in Health Policy and Management from Harvard University.